CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
35 hedge funds and large institutions have $2.5M invested in CytRx Corp in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
14% less capital invested
Capital invested by funds: $2.9M → $2.5M (-$407K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$211K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$45.3K |
| 3 |
Bank of New York Mellon
New York
|
+$45.2K |
| 4 |
VF
Virtu Financial
New York
|
+$24.4K |
| 5 |
Morgan Stanley
New York
|
+$17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$305K |
| 2 |
Millennium Management
New York
|
-$242K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$35.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.8K |
| 5 |
BlackRock
New York
|
-$12.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RE
26
RBC Europe
London,
United Kingdom
| $27 | – | – | – |
|
|
APA
27
American Portfolios Advisors
Holbrook,
New York
| $10 | – | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $2 | – | – | – |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$35.4K | -20,118 | Closed |
|
30
Simplex Trading
Chicago,
Illinois
| – | -$4.07K | -2,314 | Closed |
|
|
AG
31
Advisor Group
Phoenix,
Arizona
| – | -$155 | -88 | -38% |
|
32
Barclays
London,
United Kingdom
| – | +$2 | +1 | +50% |
|
|
NWM
33
Northwest Wealth Management
Spencer,
Iowa
| – | +$70 | +40 | New |
|
CYTR Hedge Fund Activity: Q1 2018 in Review
35 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q1 2018, worth a combined $2.5M — down 14% from $2.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CYTR positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $211K. The largest seller was D.E. Shaw & Co, cutting an estimated $305K.
- 35 institutional investors held CytRx Corp (CYTR) as of Q1 2018, up from 33 in Q4 2017.
- Funds reported $2.5M of CytRx Corp stock for Q1 2018, down 14% quarter-over-quarter.
- 4 funds opened new CytRx Corp positions in Q1 2018 and 2 closed out, a net change of +2 holders.
- The largest CytRx Corp buyer in Q1 2018 was Vanguard Group, an estimated $211K added.
- The largest CytRx Corp seller in Q1 2018 was D.E. Shaw & Co, an estimated $305K sold.
Based on aggregated 13F filings for Q1 2018.